Edition:
United Kingdom

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

67.42EUR
4:35pm BST
Change (% chg)

€0.72 (+1.08%)
Prev Close
€66.70
Open
€66.58
Day's High
€67.60
Day's Low
€66.56
Volume
629,639
Avg. Vol
864,398
52-wk High
€91.74
52-wk Low
€55.44

Latest Key Developments (Source: Significant Developments)

Fresenius Medical Care To Implement Share Buy-Back Programme
Friday, 14 Jun 2019 

June 14 (Reuters) - Fresenius Medical Care AG & Co KGaA ::WILL IMPLEMENT A SHARE BUY-BACK PROGRAMME.UP TO A MAXIMUM OF 12 MILLION ORDINARY SHARES WILL BE REPURCHASED AT A TOTAL PURCHASE PRICE OF UP TO 660 MILLION EURO.PERIOD FROM 17 JUNE 2019 UNTIL AND INCLUDING 17 JUNE 2020.3.2% OF SHARE CAPITAL OF FRESENIUS MEDICAL CARE.  Full Article

Fresenius Medical Care Places $500 Mln 10-Yr Bonds With 3.94% Yield
Friday, 14 Jun 2019 

June 14 (Reuters) - Fresenius Medical Care AG & Co KGaA ::FRESENIUS MEDICAL CARE SUCCESSFULLY PLACES USD BONDS.SUCCESSFULLY PLACED BONDS WITH AN AGGREGATE PRINCIPAL AMOUNT OF USD 500 MILLION.BONDS HAVE A MATURITY OF 10 YEARS AND AN ANNUAL COUPON OF 3.750%. THE ISSUE PRICE IS 98.461%, RESULTING IN A YIELD OF 3.938%.PROCEEDS WILL BE USED FOR GENERAL CORPORATE PURPOSES, INCLUDING THE REFINANCING OF OUTSTANDING INDEBTEDNESS.  Full Article

S&P Upgrades Fresenius Medical Care To BBB With Stable Outlook -Statement
Thursday, 23 May 2019 

May 23 (Reuters) - Fresenius Medical Care AG & Co KGaA ::S&P UPGRADES FRESENIUS MEDICAL CARE TO BBB WITH STABLE OUTLOOK.  Full Article

Fresenius Medical Care Confirms 2019 Outlook After Q1
Thursday, 2 May 2019 

May 2 (Reuters) - Fresenius Medical Care ::CONFIRMS OUTLOOK FOR 2019, EFFECTS FROM PLANNED TAKEOVER OF NXSTAGE MEDICAL INC NOT TAKEN INTO ACCOUNT.Q1 ADJUSTED REVENUE 4.13 BILLION EUR (VERSUS. 3.73 BILLION IN PREV YEAR).Q1 ADJUSTED EBIT 551 MILLION EUR (VERSUS. 506 MILLION IN PREV YEAR).Q1 ADJUSTED NET PROFIT 318 MILLION EUR (VERSUS. 296 MILLION IN PREV YEAR).  Full Article

Fresenius Medical Care Appoints Frank Maddux As Global Chief Medical Officer
Wednesday, 20 Mar 2019 

March 20 (Reuters) - Fresenius Medical Care AG & Co KGaA ::FRESENIUS MEDICAL CARE APPOINTS FRANK MADDUX AS GLOBAL CHIEF MEDICAL OFFICER.  Full Article

Cytosorbents Announces Expansion Of Cytosorb Partnership With Fresenius Medical Care
Tuesday, 22 Jan 2019 

Jan 22 (Reuters) - Cytosorbents Corp ::CYTOSORBENTS ANNOUNCES EXPANSION OF CYTOSORB® PARTNERSHIP WITH FRESENIUS MEDICAL CARE.CYTOSORBENTS - HAS EXPANDED PARTNERSHIP WITH FRESENIUS MEDICAL CARE TO KOREA & MEXICO.CYTOSORBENTS CORP - FINANCIAL TERMS OF AGREEMENT HAVE NOT BEEN DISCLOSED.CYTOSORBENTS - UNDER TERMS, FRESENIUS MEDICAL HAS EXCLUSIVE RIGHTS TO DISTRIBUTE CYTOSORB FOR ACUTE CARE, OTHER HOSPITAL APPLICATIONS IN KOREA & MEXICO.CYTOSORBENTS - COMMERCIAL SALES OF CYTOSORB EXPECTED TO START AFTER SECURING MARKET REGISTRATION CLEARANCE FROM KOREAN & MEXICAN HEALTH AUTHORITIES.  Full Article

Fresenius Medical Care Awaiting U.S. FTC Decision On NxStage Medical Acquisition
Friday, 28 Dec 2018 

Dec 28 (Reuters) - Fresenius Medical Care AG & Co KGaA ::DGAP-NEWS: FRESENIUS MEDICAL CARE AWAITING U.S. FEDERAL TRADE COMMISSION DECISION ON NXSTAGE MEDICAL ACQUISITION.FRESENIUS MEDICAL CARE - NOW EXPECTS NXSTAGE MEDICAL TRANSACTION TO CLOSE IN EARLY 2019 .  Full Article

Fresenius Medical Care Acquires Renal Hospitals And Dialysis Centers In China
Wednesday, 5 Dec 2018 

Dec 5 (Reuters) - Fresenius Medical Care AG & Co KGaA ::CARE ANNOUNCES ACQUISITION OF RENAL HOSPITALS AND DIALYSIS CENTERS IN CHINA.COMPANY ACQUIRED A 70% SHARE OF GUANGZHOU KANGNIDAISI MEDICAL INVESTMENT CO., LTD,.ALSO ACQUIRED 55% STAKES IN HENAN AISHEN AND AISHEN BEIJING.  Full Article

Fresenius Medical Care Net Income Down 8 Pct
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - Fresenius Medical Care : :REVENUE IN THE THIRD QUARTER 2018 DECREASED BY 6% TO EUR 4,058 MILLION.REVENUE IN THE THIRD QUARTER 2018 DECREASED BY 6% TO EUR 4,058 MILLION (-6% AT CONSTANT CURRENCY).HEALTH CARE SERVICES REVENUE DECREASED BY 8% TO EUR 3,258 MILLION (-8% AT CONSTANT CURRENCY).ON A COMPARABLE BASIS, CARE COORDINATION REVENUE DECLINED BY 22% (-27% AT CONSTANT CURRENCY).IN THE FIRST NINE MONTHS OF 2018, REVENUE DECREASED BY 8% TO EUR 12,247 (-2% AT CONSTANT CURRENCY).TOTAL EBIT REACHED EUR 527 MILLION IN THE THIRD QUARTER OF 2018, A DECREASE OF 13% (-20% AT CONSTANT CURRENCY).THE STRONG DECREASE WAS MAINLY ATTRIBUTABLE TO THE HIGHER COMPARABLE BASE WHICH INCLUDED THE EBIT CONTRIBUTION FROM SOUND OF EUR 20 MILLION.NET INCOME ATTRIBUTABLE TO SHAREHOLDERS OF FRESENIUS MEDICAL CARE AG & CO. KGAA DECREASED BY 8% TO EUR 285 MILLION IN THE THIRD QUARTER OF 2018 (-17% AT CONSTANT CURRENCY).THE COMPANY EXPECTS REVENUE3 GROWTH BETWEEN 2% AND 3% AT CONSTANT CURRENCY IN 2018.NET INCOME ON A COMPARABLE BASIS IS EXPECTED TO INCREASE BY 11% TO 12% AT CONSTANT CURRENCY.GROWTH DID NOT ACCELERATE TO THE EXTENT PREVIOUSLY PROJECTED. WE ANTICIPATE THE IMPACT FROM THE CURRENT LEVEL OF GROWTH AND LESS ACQUISITIONS TO CONTINUE IN THE FOURTH QUARTER. .  Full Article

Fresenius Medical Care To Implement Share Buy-Back Programme
Friday, 25 May 2018 

May 25 (Reuters) - FRESENIUS MEDICAL CARE AG & CO KGAA ::WILL IMPLEMENT A SHARE BUY-BACK PROGRAMME.UP TO A MAXIMUM OF 431,000 ORDINARY SHARES WILL BE REPURCHASED AT A TOTAL PURCHASE PRICE OF UP TO 39 MILLION EURO.  Full Article

Photo

Will Europe's clampdown on faulty medical devices hurt patients?

BERLIN When a Californian company founded by a U.S. veteran wounded in Afghanistan sought to register a new medical device this year, it turned to Europe before the United States. The European approvals system had long been quicker, the company said, but the introduction of new rules is changing all that.